首页|期刊导航|药物分析学报:英文版|Pharmacokinetics,distribution,and excretion of sodium oligomannate,a recently approved anti-Alzheimer''''s disease drug in China
药物分析学报:英文版2022,Vol.12Issue(1):P.145-155,11.DOI:10.1016/j.jpha.2021.06.001
Pharmacokinetics,distribution,and excretion of sodium oligomannate,a recently approved anti-Alzheimer''''s disease drug in China
摘要
关键词
Sodium oligomannate/Alzheimer’s disease/Pharmacokinetics/LC-MS/MS/Oligosaccharide分类
医药卫生引用本文复制引用
Jiaojiao Lu,Qiongqun Pan,Jieqiang Zhou,Yan Weng,Kaili Chen,Lv Shi,Guanxiu Zhu,Chunlin Chen,Liang Li,Meiyu Geng,Zhenqing Zhang..Pharmacokinetics,distribution,and excretion of sodium oligomannate,a recently approved anti-Alzheimer''''s disease drug in China[J].药物分析学报:英文版,2022,12(1):P.145-155,11.基金项目
supported by the National Natural Science Foundation of China(Grant No.:81673388) (Grant No.:81673388)
the Jiangsu Key Laboratory of Translational Research and Therapy for Neuro-Psycho-Diseases(Grant No.:BM2013003) (Grant No.:BM2013003)
the Priority Academic Program Development of Jiangsu Higher Education Institutes(PAPD) (PAPD)